<?xml version="1.0" encoding="UTF-8"?>
<wcm:root xmlns:wcm="http://www.stellent.com/wcm-data/ns/8.0.0">
  <wcm:element name="MainContent">&lt;p&gt;&lt;strong&gt;PLEASE NOTE: THIS MEETING HAS BEEN POSTPONED. PLEASE FIND MORE INFORMATION &lt;a target="" href="[!--$wcmUrl('link','UCM272789')--]"&gt;HERE&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Date:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;November 2-3, 2011&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Time: &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;The meeting will be held on November 2, 2011, from 9:00 a.m. to 5:00 p.m., and on November 3, 2011, from 8:00 a.m. to 5:00 p.m. On November 2, 2011, from 9:00 a.m. to 12:00 p.m., the meeting will be closed to permit discussion and review of trade secret and/or confidential commercial information (5 U.S.C. 552b(c)(4)).&amp;nbsp; The meeting will be open to the public on November 2, 2011, from 1:00 p.m. to 5:00 p.m., and on November 3, from 8:00 a.m. to 5:00 p.m.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Location:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Center for Tobacco Products&lt;br /&gt;9200 Corporate Blvd.&lt;br /&gt;Rockville, MD 20850&lt;/p&gt;&lt;p&gt;Seating for this meeting may be limited, so the public is encouraged to watch the&lt;br /&gt;free webcast instead of traveling to the meeting.&amp;nbsp; The link for the webcast will be&lt;br /&gt;available by 9:00 a.m. on November 2, 2011, on the &lt;a target="" href="[!--$wcmUrl('link','UCM237359')--]"&gt;TPSAC website&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;The link will become active shortly before the open session begins at 1:00&amp;nbsp; p.m. on November 2, 2011.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Agenda:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;The committee will continue the discussions of issues related to the nature and impact of the use of dissolvable tobacco products on the public health, including such use among children, as part of the TPSAC&amp;rsquo;s required report to the Secretary of Health and Human Services.&amp;nbsp;&amp;nbsp; Discussion will include such topics as the composition and characteristics of dissolvable tobacco products, product use, potential health effects, and marketing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Meeting Materials:&lt;br /&gt;&lt;/strong&gt;&amp;nbsp;&lt;br /&gt;Links to meeting materials will be added as they become available.&amp;nbsp; FDA intends to make complete background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA&amp;rsquo;s Web site after the meeting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Public Participation Information:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.&lt;/p&gt;&lt;p&gt;Written submissions may be made to the contact person on or before October 19, 2011.&amp;nbsp; Please send 20 paper copies, and one electronic copy,&amp;nbsp; of your submission to:&lt;/p&gt;&lt;p&gt;Caryn Cohen, M.S.&lt;br /&gt;Office of Science&lt;br /&gt;Center for Tobacco Products&lt;br /&gt;Food and Drug Administration&lt;br /&gt;9200 Corporate Blvd. &lt;br /&gt;Rockville, MD 20850&lt;/p&gt;&lt;p&gt;Copies must be received by 4 p.m. (Eastern) on October 19, 2011.&lt;/p&gt;&lt;p&gt;Oral presentations from the public will be scheduled between approximately &lt;br /&gt;11 a.m. and 12 p.m. on November 3, 2011.&amp;nbsp; Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before October 11, 2011.&lt;/p&gt;&lt;p&gt;Time allotted for each presentation may be limited.&amp;nbsp; If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session.&amp;nbsp; The contact person will notify interested persons regarding their request to speak by October 12, 2011.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Contact Information:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Caryn Cohen, M.S.&lt;br /&gt;Center for Tobacco Products&lt;br /&gt;Food and Drug Administration&lt;br /&gt;9200 Corporate Boulevard &lt;br /&gt;Rockville, MD 20850&lt;/p&gt;&lt;p&gt;Phone:&amp;nbsp; 1-877-287-1373 (choose Option 4)&amp;nbsp; &lt;br /&gt;Fax:&amp;nbsp; 240-276-3761&amp;nbsp; &lt;br /&gt;Email:&amp;nbsp; &lt;a href="mailto:TPSAC@fda.hhs.gov"&gt;TPSAC@fda.hhs.gov&lt;/a&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;FDA Advisory Committee Information Line&lt;br /&gt;1-800-741-8138&lt;br /&gt;(301-443-0572 in the Washington DC area)&lt;br /&gt;Code: 8732110002&lt;br /&gt;Please call the Information Line for up-to-date information on this meeting.&lt;/p&gt;&lt;p&gt;A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice.&amp;nbsp; Therefore, you should always check the agency&amp;rsquo;s Website and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting.&lt;/p&gt;&lt;p&gt;FDA intends to make background material available to the public no later than 2 business days&lt;br /&gt;before the meeting.&amp;nbsp; If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA&amp;rsquo;s Web site after the meeting.&lt;/p&gt;&lt;p&gt;Persons attending FDA&amp;rsquo;s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets.&amp;nbsp; FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs.&amp;nbsp; If you require special accommodations due to a disability, please contact Caryn Cohen at least 7 days in advance of the meeting.&amp;nbsp; FDA is committed to the orderly conduct of its advisory committee meetings.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Please visit our Web site at &lt;a href="http://www.fda.gov/oc/advisory/default.htm"&gt;http://www.fda.gov/oc/advisory/default.htm&lt;/a&gt; for procedures on public conduct during advisory committee meetings.&lt;/p&gt;&lt;p&gt;Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app.2). &lt;br /&gt;&amp;nbsp;&lt;/p&gt;</wcm:element>
<wcm:element name="MainList1"></wcm:element>
  <wcm:element name="MainList2"></wcm:element>
  <wcm:element name="MainList3"></wcm:element>
</wcm:root>
